alpha62539

MDT is set to recover - overreaction on the outlook

NYSE:MDT   Medtronic plc.
MDT beat analysts' estimates but guided somewhat dovish. The market has penalized the stock - it could be an overreaction. The management executes well on the business. I expect higher prices.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。